Advertisement
Person › Details
Philippe Pouletty (Truffle Capital (FR))
Pouletty, Philippe (Truffle Capital 201508 General Partner + Deinove Chairman)
Organisation | Truffle Capital (FR) | |
Former/major organisation | Abivax S.A. (Euronext Paris: ABVX) | |
Group | Abivax (Group) | |
Product | venture capital | |
Product 2 | LIFE SCIENCES | |
Record changed: 2023-07-27 |
Advertisement
More documents for Philippe Pouletty
- [1] Carbios S.A.. (7/11/23). "Press Release: Carbios Announces the Success of Its Capital Increase with Preferential Subscription Rights of Approximately 141 Million Euros, the Largest on Euronext Growth since 2015". Clermont-Ferrand....
- [2] Carbios S.A.. (6/22/23). "Press Release: Carbios Announces the Launch of a Rights Issue Totalling around €122 Million, Likely to Be Increased to around €141 Million if the Extension Clause Is Fully Exercised". Clermont-Ferrand....
- [3] Diaccurate S.A.. (9/8/21). "Press Release: Diaccurate Acquires Clinical Stage Sole-in-Class Targeted Cancer Therapy from Merck KGaA, Darmstadt, Germany". Paris....
- [4] Truffle Capital. (12/18/19). "Press Release: Truffle Capital Successfully Raises nearly €400 Million for New Venture Capital Funds Funds backed by top-tier French and international institutional investors". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top